Published in Blood Weekly, February 12th, 2004
Entelos will use its proprietary PhysioLab technology to build a fully functional model in just months. The resulting systems biology platform will support a broad range of research objectives of J&JPRD as they relate to Ortho Biotech Products, L.P. and Janssen-Cilag products Procrit and Eprex.
PhysioLab platforms encompass dynamic,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.